Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Powell

Showing results (111-120 of 137) with videos related to

Pageof 14
Sort By:
Immunohorizons|June 26, 2023
Serendipitous Discovery of T Cell-Produced KLK1b22 as a Regulator of Systemic MetabolismMatthew L Arwood, Im-Hong Sun, Chirag H Patel, et al.
Blood|October 17, 2021
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learningShannon R McCurdy, Vedran Radojcic, Hua-Ling Tsai, et al.
Nature Communications|February 16, 2022
Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancerAlok Kumar Singh, Monali Praharaj, Kara A Lombardo, et al.
Nature Communications|March 24, 2026
Retraction Note: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancerAlok Kumar Singh, Monali Praharaj, Kara A Lombardo, et al.
Science Advances|November 25, 2015
The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironmentMadhav D Sharma, Rahul Shinde, Tracy L McGaha, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2015
Targeting glutamine metabolism rescues mice from late-stage cerebral malariaEmile B Gordon, Geoffrey T Hart, Tuan M Tran, et al.
Communications Biology|March 19, 2022
Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in miceAlvaro A Ordonez, C Korin Bullen, Andres F Villabona-Rueda, et al.
Immunity|January 12, 2010
The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activationMuhammet F Gulen, Zizhen Kang, Katarzyna Bulek, et al.
Nature Immunology|May 7, 2013
Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathwaysJiyeon S Kim, Tammarah Sklarz, Lauren B Banks, et al.
Blood|February 4, 2010
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host diseaseLeo Luznik, Javier Bolaños-Meade, Marianna Zahurak, et al.
Pageof 14

Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
Immunohorizons|June 26, 2023
Serendipitous Discovery of T Cell-Produced KLK1b22 as a Regulator of Systemic MetabolismMatthew L Arwood, Im-Hong Sun, Chirag H Patel, et al.
Blood|October 17, 2021
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learningShannon R McCurdy, Vedran Radojcic, Hua-Ling Tsai, et al.
Nature Communications|February 16, 2022
Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancerAlok Kumar Singh, Monali Praharaj, Kara A Lombardo, et al.
Nature Communications|March 24, 2026
Retraction Note: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancerAlok Kumar Singh, Monali Praharaj, Kara A Lombardo, et al.
Science Advances|November 25, 2015
The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironmentMadhav D Sharma, Rahul Shinde, Tracy L McGaha, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2015
Targeting glutamine metabolism rescues mice from late-stage cerebral malariaEmile B Gordon, Geoffrey T Hart, Tuan M Tran, et al.
Communications Biology|March 19, 2022
Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in miceAlvaro A Ordonez, C Korin Bullen, Andres F Villabona-Rueda, et al.
Immunity|January 12, 2010
The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activationMuhammet F Gulen, Zizhen Kang, Katarzyna Bulek, et al.
Nature Immunology|May 7, 2013
Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathwaysJiyeon S Kim, Tammarah Sklarz, Lauren B Banks, et al.
Blood|February 4, 2010
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host diseaseLeo Luznik, Javier Bolaños-Meade, Marianna Zahurak, et al.
Pageof 14